The use of gabapentin in cats with kidney disease necessitates lower dosages and more frequent monitoring. A standard dose for a healthy cat may be too high for a cat with CKD, increasing the risk of side effects, such as sedation, lethargy, or, rarely, neurological issues. Objectives: To evaluate the pharmacokinetics of clinically relevant dosing regimens of gabapentin in cats. Animals: Eight research-purpose mixed-breed cats. Methods: Cats were enrolled in a serial order, non-randomized pharmacokinetic study. Gabapentin is an anticonvulsant drug, which presents an established clinical efficacy in human patients for the management of refractory partial seizures, secondarily generalized tonic-clonic seizures, and for the control of chronic neuropathic pain. Gabapentin was synthesized as a structural analog Greyhound dogs for gabapentin in dogs is 10-20 mg/kg [4.5 - 9.1 mg/lb] every 8 hours [10]. Plumb’s recommends gabapentin at 5-10 mg/kg [2.3 - 4.5 mg/lb] every 12 hours for chronic pain [11]. Although the bioavailability data of gabapentin comes from human research, it is possible that a similar inverse relationship Dose-normalized gabapentin serum concentrations at 3 h and 8 h were compared between cats with CKD receiving 10 mg/kg and both normal cats receiving 20 mg/kg and normal cats receiving 10 mg/kg using a Mann–Whitney test. Objective—To determine the pharmacokinetics of gabapentin in cats after IV and oral administration. Animals—6 healthy female adult domestic shorthair cats. Procedures—Gabapentin was administered IV (4 mg/kg) or orally (10 mg/kg) in a crossover randomized design. Blood samples were obtained immediately before gabapentin administration and Overview: Gabapentin is a common medication prescribed for dogs suffering from various ailments, including seizures, anxiety, and pain. Knowing how long Gabapentin lasts in a dog’s system is crucial for understanding its effectiveness, potential side effects, and the need for regular administration. Cats were enrolled in a serial order, non‐randomized pharmacokinetic study. Gabapentin was administered as an IV bolus (5 mg/kg), orally (10 mg/kg) as a single dose or twice daily for 2 weeks, or as a transdermal gel (10 mg/kg) in serial order. Serial blood samples were collected up to 48 hours. Gabapentin is rapidly absorbed and eliminated in both canine and feline patients. 8 Frequent administration is needed to maintain minimum target plasma concentrations. 8 Pharmacokinetic data suggest that gabapentin should be dosed at 10 mg/kg every 8 hours in dogs, 8 and 8 mg/kg every six hours in cats. 9. Administration of gabapentin on an as In dogs, however, 30–40% of the orally administered dose of gabapentin undergoes hepatic metabolism to N-methyl-gabapentin. Despite undergoing some hepatic metabolism in dogs, there is no appreciable induction of hepatic microsomal enzymes in this species. The t ½ for gabapentin in dogs and cats is between 3 and 4 hrs. This review aimed to clarify gabapentin use and pharmacokinetic aspects to promote conscious use in dogs, cats, and horses. In dogs, gabapentin was useful in the treatment of epilepsy, as well as chronic, neuropathic, and post-operative pain and anxiety. Gabapentin for dogs is commonly prescribed for pain, anxiety, or seizures. It's generally safe, but there are some known side effects to be aware of. Gabapentin has a high oral bioavailability in dogs (80 per cent administered at a dose of 50mg/kg) 8. and its absorption in the small intestine is not influenced by dietary factors. 9. In dogs, 30 per cent to 40 per cent of the administered oral dose of gabapentin undergoes hepatic metabolism to N-methyl-gabapentin and is excreted by the Clinical Applications. Gabapentin has been used as an adjunct treatment for seizures in dogs and cats and as treatment for neuropathic pain. 4-9 Gabapentin may be effective as an adjunct treatment for acute pain in humans (eg, pain following some surgeries, including spinal surgery and hysterectomy) and, to a lesser extent, in dogs and cats. 10-16 This review aimed to clarify gabapentin use and pharmacokinetic aspects to promote conscious use in dogs, cats, and horses. In dogs, gabapentin was beneficial in the treatment of epilepsy, as well as chronic, neuropathic, and post-operative pain, as well as anxiety. Gabapentin plasma concentrations after administration as an IV bolus (5 mg/kg) in 8 cats (open diamonds) with modeled timeconcentration curve (using geometric mean of derived parameters; solid Gabapentin is the most commonly prescribed medication for the treatment of chronic musculoskeletal pain in cats. Despite this common and chronic usage, clinically relevant pharmacokinetic data is lacking. To evaluate the pharmacokinetics of clinically relevant dosing regimens of gabapentin in cats. Eight research-purpose mixed-breed cats. Older cats may metabolize Gabapentin more slowly than younger cats, leading to a longer duration of action. 2. Overweight cats may require higher doses of Gabapentin to achieve the same level of pain relief, which can also affect how long the medication lasts in their system. Specifically, the terminal half-life of gabapentin in cats, when administered orally, is approximately 3.63 hours (ranging from 2.96 to 4.77 hours) for a single dose, and 3.72 hours (ranging from 3.12 to 4.51 hours) for repeated doses. Several case reports note analgesia when gabapentin was used for treatment of chronic pain. 14,15 And in a clinical study on postoperative pain in dogs undergoing mastectomy, although pain scores did not differ, dogs receiving NSAIDs plus gabapentin required fewer opioid rescue doses than dogs receiving NSAIDs alone; thus, the gabapentin did
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | |
![]() | ![]() |
![]() | |
![]() | ![]() |
![]() | |
![]() | ![]() |